Oxurion N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OXUR.BR research report →
About the company
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N. V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide.
- CEO
- Pascal Ghoson
- IPO
- 2006
- Employees
- 11
- HQ
- Leuven, BE
Price Chart
- Market Cap
- $210.29K
- P/E
- -0.02
- P/S
- 0.38
- P/B
- -0.01
- EV/EBITDA
- -3.10
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -590.81%
- Net Margin
- -671.71%
- ROE
- 29.96%
- ROIC
- 341.92%
- Revenue
- $555.00K · 18400.00%
- Net Income
- $-3,728,000 · -3232.77%
- EPS
- $-0.13 · -238.59%
- Op Income
- $-3,629,000
- FCF YoY
- 17.55%
- 52W High
- $0.08
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- -0.15
- Avg Volume
- 1.12M
Get TickerSpark's AI analysis on OXUR.BR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our OXUR.BR coverage
Recent articles, reports, and earnings notes.
No research on OXUR.BR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OXUR.BR report →Similar companies
Peers in the same neighborhood.